NuVasive Inc $33.83

up +0.40


17/4/2014 05:20 PM  |  NASDAQ : NUVA  
Industries : Health Services / Medical Appliances & Equipment
Get Trend Analysis Icon Get NUVA Trend Analysis - it has outperformed the S&P 500 by 47%

Partner Headlines

  1. NuVasive Announces $30M Unfavorable Jury Verdict for Use of Trade-Name ...

    Benzinga
  2. NuVasive Up After Q4 Beat, Despite Cautious Guidance

    IBD
  3. Ukraine Unrest Sparks Selling But Some Biotechs Firm Up

    IBD
  4. Earnings Scheduled For March 3, 2014

    Benzinga
  5. Stocks Hitting 52-Week Highs

    Benzinga
  6. NuVasive pops to 3-year high

    IBD
  7. Mid-Afternoon Market Update: Markets Nearly Erase Early Year Losses as ...

    Benzinga
  8. Mid-Day Market Update: Dow Jumps 120 Points; Fastenal Shares Drop On Downbeat ...

    Benzinga
  9. NuVasive Preliminary Q4 Sales Beat, Stock Jumps

    IBD
  10. Mid-Morning Market Update: Markets Rise; Bank of America Profit Beats Estimates

    Benzinga
  11. Benzinga's Volume Movers

    Benzinga
  12. Stocks Hitting 52-Week Highs

    Benzinga
  13. UPDATE: Goldman Sachs Downgrades NuVasive as Industry Headwinds, Valuation ...

    Benzinga
  14. Benzinga's Top Downgrades

    Benzinga
  15. Benzinga's Top Initiations

    Benzinga
  16. Market Wrap For Wednesday, July 31: Stocks Mostly Unchanged Despite Upbeat ...

    Benzinga
  17. Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Green Dot Rises

    Benzinga
  18. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga
  19. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga
  20. Benzinga's Top Upgrades

    Benzinga
  21. NuVasive Announces First Patient in the United States Treated With the ...

    Benzinga
  22. NuVasive(R) Announces Release of $62.5M From Escrow Following Appeals Court ...

    Benzinga
  23. NuVasive to Release $62.5M from Escrow Following Appeals Court Win

    Benzinga
  24. Covidien Stock Rises After Earnings Beat Estimates

    IBD
  25. NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System

    Benzinga
  26. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus
  27. Benzinga's Top Downgrades

    Benzinga
  28. UPDATE: Goldman Sachs Reduces PT to $16 on NuVasive on Sales Outlook

    Benzinga
  29. Intuitive Surgical Stock Rebounds From Q3 Dive

    IBD
  30. Intuitive Surgical Stock Upgraded Ahead Of Q3 Report

    IBD
  31. FDA Ruling on Artificial Disc Boosts Globus Medical

    IBD
  32. The Hell With NuVasive Stock: Get Hired by One of its Competitors at $1M

    YCharts
  33. Stocks Post Gains after Positive Data with Bank of America (BAC) and Alcoa ...

    MarketIntelligenceCenter
  34. Nuvasive (NUVA) Drops 33% on Weak Q3 Revenue

    MarketIntelligenceCenter
  35. Benzinga Mid-Afternoon Market Update

    Benzinga
  36. Stock Futures Point to Higher Open Ahead of Data with Facebook (FB) and ...

    MarketIntelligenceCenter
  37. UPDATE: BMO Capital Markets Downgrades NuVasive to Underperform on Outlook

    Benzinga
  38. Benzinga Mid-Morning Market Update

    Benzinga
  39. US Stock Futures Up; Jobless Claims, ECB Meeting In Focus

    Benzinga
  40. Stocks To Watch For October 4, 2012

    Benzinga
  41. Nuvasive

    IBD
  42. NuVasive Cuts Q3 Prelim Revenue, Forecast $147M

    Benzinga
  43. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus
  44. Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying

    Benzinga
  45. Analyst Upgrades: NUVA, ONXX, and SKUL

    SchaeffersResearch
  46. Analyst Upgrades: NUVA, QCOM, and SPWR

    SchaeffersResearch
  47. NuVasive Up 20% After Q1 Earnings

    Benzinga
  48. NuVasive Inc. Reports Operating Results (10-K)

    GuruFocus
  49. Top 4 Small-Cap Stocks In The Healthcare Sector With The Highest Cash

    Benzinga
  50. UPDATE: BMO Capital Markets Increases Target to $16 on Nuvasive

    Benzinga
Trading Center